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Aim:   60% of all infections are estimated to be biofilm related and to cost more than 1 billion 
dollars per year in USA alone, emphasizing the importance of the field. The biofilm community, its 
spatial distribution and activity play an important role in the prolongation of treatment and healing 
of chronic infections and is clearly different from acute infections by planktonic microorganisms. The 
purpose of this presentation is to describe different aspects and challenges of biofilms. How to 
improve sampling, diagnosis and treatment of chronic infections, especially considering the biofilm 
issue, will be presented. 
Methods: Systematic and optimized sampling of various specimen types from patients with chronic 
biofilm infections was performed. Extended culture and a panel of molecular biological tools were 
applied on the different types of specimens for improved diagnosis. For further investigation of the 
microbial pathogenesis, in situ transcriptomics and metabolomics were applied.   
Results:  In chronic biofilm related infections, molecular techniques detected a larger diversity of 
microorganisms than culture based methods in several patients. A heterogeneous distribution of 
bacteria in various specimens from the same patient was evident. In chronic wounds, multiple 
biopsies from the same ulcer showed large differences in the abundance of fx P. aeruginosa and S. 
aureus at different locations. Transcriptomic and metabolomic analyses resolved the important 
virulence genes and nutrient acquisition mechanisms of S. aureus in vivo and a capability to survive 
under severe oxygen limitation. 
Conclusion: Our studies show that improved diagnosis and understanding of chronic biofilm related 
infections required multiple specimen types, standardized sampling, extended culture and molecular 
biological analysis. The use of a well-designed diagnostic algorithms, big data and personalized 
diagnosis and treatment has large potentials and will be discussed during the presentation. 
 
 
